Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

<p>Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.</p><p><br /></p><p><b>What You’ll Learn:</b></p><ul><li>Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.</li><li>Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.</li><li>Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.</li></ul><p><br /></p><p><b>Why Listen?</b></p><ul><li>Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.</li><li>Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.</li><li>Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.</li></ul><p>“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay. </p><p><br /></p><p>This podcast is why we partnered with them.”<br />– Digital Health Startup CEO</p><p><br /></p><p>New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.</p><p><br /></p><p>Brought to you by <a href="https://www.bioaccessla.com/">bioaccess®</a> – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.</p>

Scott Stout, CEO & Co-Founder at MedVector Clinical Trials

This episode features Scott Stout, who is helping reshape clinical trial recruitment through MedVector’s innovative HCP Recruitment model. By engaging community physicians in a new way, MedVector enables access to larger and more diverse patient populations for clinical trial sites. Their approach allows trusted healthcare providers and their patients to benefit from clinical trials as a care option—without requiring physicians to become investigators or risking patient leakage. By aligning p...

12-19
36:09

Matteo Talotta, Director of Clinical Solutions at Biorce

This episode features Matteo Talotta, a global leader with experience across banking, academia, government, and a wide range of organizations — from start-ups and scale-ups to large multinationals. After working in Canada, Italy, the U.S., Spain, and Romania, Matteo brings a rich, multicultural perspective to the world of clinical innovation. Fluent in four languages and driven by collaboration, his career has led him to focus on the transformative power of AI in biotechnology. He is currentl...

12-12
30:19

Sonal Pendharkar Kulkarni, Co-founder & CSO at Uvisa Health

In this episode, we’re joined by Sonal Pendharkar Kulkarni, Ph.D., Co-founder and Chief Science Officer at Uvisa Health. With a background that bridges women’s health, the microbiome, digital health innovation, and medical device development, Sonal is at the forefront of creating smarter, science-driven solutions for vaginal health management. Sonal shares her journey from research scientist to entrepreneur, the insights that shaped Uvisa Health’s mission, and the importance of designing prod...

12-05
27:14

David Kraemer, Founder & Managing Member at 10 || 2 Capital Partners

In this episode, we sit down with David M. Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across public and private markets, David shares insights on capital formation, innovation, and navigating complex investment landscapes. From biotech and MedTech to AI, robotics, and venture capital, his perspective bridges finance and technology in today’s fast-changing world. Tune in to hear how he’s built gl...

10-30
30:38

Joseph Palumbo, Head of R&D & Chief Medical Officer at BioVie Inc

Today we’re joined by Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with more than three decades of leadership in psychiatry, neurology, and neurodegenerative research. Dr. Palumbo has led groundbreaking work across the full R&D spectrum—from preclinical innovation to global drug approvals—advancing programs valued at over $1 billion. He has held senior leadership roles as Global Head of Psychiatry at Johnson & Johnson, Vice President & Fel...

10-10
36:20

Nicholas Kadysh, CEO at PharmAla Biotech

In this episode, we welcome Nicholas Kadysh, CEO of PharmAla Biotech, the company pioneering GMP MDMA production and named the top-performing stock on the Canadian capital markets in 2023 by The Market Herald. As Chair of Psychedelics Canada, Nicholas has been instrumental in advancing legal and ethical standards, building strong relationships with government, and shaping a regulatory landscape where healthcare innovation can thrive. His leadership has also been recognized by The Peak, ...

09-26
32:51

Carolina Alarco, Founder & Principal, Bio Strategy Advisors

In this episode, we sit down with Carolina [Last Name], a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. Carolina is the Founder & Principal of Bio Strategy Advisors, serves on multiple biotech and nonprofit boards, and is the Co-Founder & Co-Chair of Latinos in Bio. She shares insights from her leadership journey at companies like Genzyme, Aegerion Pharmaceuticals, and Novelion Therapeutics, and discusses the future of biotech, the ...

09-19
37:17

Jason Hurt, Founder & CEO of Theragnostic Insights

In this episode, we are joined by Dr. Jason Hurt, a clinician-scientist and entrepreneur with extensive experience in radiopharmaceutical development, clinical trial strategy, and oncology drug development. In March 2025, Dr. Hurt founded Theragnostic Insights, a consulting and strategic advisory firm focused on advancing theranostic solutions and radioligand therapies—pioneering approaches that are shaping the future of cancer treatment.

09-12
25:02

Robert Bilkovski, CEO at medAppraise Inc.

Robert serves as the CEO for medAppraise Inc., a health technology startup focused on transforming the health and wellness of employees in large industrial corporations through the use of a state-of-the-art musculoskeletal health evaluation solution. In addition, Robert currently serves as president of RNB Ventures Consulting Inc, which is a medical device/technology consultancy firm. RNB Ventures Consulting aim is to provide medical/clinical affairs consulting expertise to medical device and...

12-06
21:11

Ramgopal P. Rao, CEO at LensGen, Inc.

Ram is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry. Ramgopal is Inventor, Founder, and Chief Executive Officer of LensGen, Inc., a clinical-stage medical device company that is developing a novel intraocular lens for presbyopia. The Company has received support from one of the largest medical device companies in the world, and this led to LensGen closing a $28.0 million Series A Financing in May 2018. Currently, he is also Chairman of...

11-23
22:05

Laura Minarsch, President at MMC Medical International Services

Laura Minarsch, R.T. RCIS, CVT, is a senior clinical affairs strategist and President of MMC Medical International Services. She consults for several novel innovative device companies in the MedTech space and has facilitated numerous acquisitions over her career spanning more than 25 years. Her track record is based on successful and strategically planned “First in Human” submissions and clinical studies in Europe, Canada, South America, New Zealand, and Australia. She has been instrumental i...

10-26
20:26

Guy Vinograd, CEO at bio-T

Guy Vinograd is CEO at bio-T, a seasoned high-tech executive and an expert software architect of cloud platforms for medical devices. As an industry leader he is a popular speaker and the organizer of the meet-up group: Smart IoMT Product Experts of Israel. Guy has co-founded bio-T, the first and leading medical IoT cloud platform designed to enable medical device vendors to fully realize the potential of the data collected by their devices. Guy is considered a leading expert of Amazon Web Se...

10-20
17:28

Lishan Aklog, Chairman and CEO at PAVmed Inc.

Dr. Aklog is an adult heart surgeon/entrepreneur and Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a multi-product medical device company which he co-founded based in 2014 on a portfolio of five of his own inventions. He previously co-founded Pavilion Holdings Group LLC which created four medical device companies including venture-backed Vortex Medical which developed and commercialized his life- saving invention AngioVac® and was sold in 2012 to Angiodynamics (Nasdaq: ANGO). Dr. Aklog re...

10-12
11:33

James Jordan, President & CEO at Pittsburgh Life Sciences Greenhouse

James F. Jordan is President/CEO at Pittsburgh Life Sciences Greenhouse and a healthcare professor at Carnegie Mellon University. Mr. Jordan is an accomplished Fortune 20-level executive with strong experience in the industry, consulting, and academia and is a recognized expert in market development and guiding the successful formation of entrepreneurial start-up businesses in the life sciences and healthcare industries. Prior to joining the PLSG, Mr. Jordan served as Senior Vice President of...

10-04
13:11

Miriam Serrano, Clinical Research Expert

Miriam is a seasoned professional in Health and Law, specializing in Sanitary Regulation and Clinical Research. With over 20 years of experience, she has a track record in planning and executing global, regional, and local clinical development programs, including Bioequivalence studies and Phase I-IV clinical trials. Her expertise spans Clinical Monitoring, Quality Assurance, Budgeting, Contracts & Payments Control, Clinical Trial Supplies, Master File, Pharmacovigilance, and Regulatory A...

09-06
26:30

Luis Alvarez, CEO and Founder of Theradaptive

Luis is the CEO and Founder of Theradaptive and developed the concept for targeted therapeutic delivery during and following a combat tour in Iraq where several of his soldiers suffered severe extremity injuries. Previously, Luis was the co-founding Deputy Director of the Department of Defense Regenerative Medicine Program and led the department's largest recombinant biologics program through Phase II. Luis was a DARPA Service Chief Fellow and Academy Professor at the United States Military A...

03-01
16:55

Etienne Nichols, Medical Device Guru

Etienne Nichols is a Medical Device Guru and Mechanical Engineer who loves learning and teaching how systems work together. He has manufacturing and product development experience, even aiding in developing combination drug-delivery devices, from startups to Fortune 500 companies, and holds a Project Management Professional (PMP) certification. Etienne has managed cross-functional teams for updating legacy products as well as developing new medical devices. His expansive knowledge, experience...

02-23
31:51

Ruben Gaitan Ortiz, CEO at Alandra Medical

Ruben is the CEO of Alandra Medical. He has dual qualifications in engineering and technology entrepreneurship combined with 16 years of experience in medical device development. Self-motivation, adaptability, trainability, and entrepreneurial drive are his key tools for achieving personal and business goals. Ruben started his career developing hardware and software for medical devices, spending countless hours reading scientific papers, twitching circuits, refining algorithms, and preparing ...

02-16
36:54

Ernesto M. Nogueira, CEO at ValueConnected

Ernesto has 27 years of experience leading healthcare strategies to drive access and expansion for new products, developing value propositions for public and private stakeholders, and assessing global market opportunities for healthcare companies. He has worked for both government agencies and global healthcare companies in roles ranging from strategic marketing and new product development to health economics and reimbursement. Also, Ernesto led several Market Access projects across the US, E...

02-09
32:57

Antonio Trujillo, Ph.D, Health Economist & Professor

Dr. Antonio Trujillo is an Associate Professor in the Department of International Health with expertise in health economics, the economics of aging, and applied econometrics. Antonio is the co-director of the Master of Health Science (MHS) in Global Health Economics degree program. He teaches an advanced econometrics course on program impact evaluation using observational data and a course on behavioral economics and public health.

01-26
37:08

Recommend Channels